PAVmed Inc (PAVM)
NASDAQ:PAVM
Want to see PAVM full AI Analyst Report?
Total Valuation
PAVmed has a market cap or net worth of $45.75M. The enterprise value is $13.98M.
Market Cap$45.75M
Enterprise Value$13.98M
Share Statistics
PAVmed has 7,159,034 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding7,159,034
Owned by Insiders13.42%
Owned by Institutions6.78%
Financial Efficiency
PAVmed’s return on equity (ROE) is 0.01 and return on invested capital (ROIC) is -61.17%.
Return on Equity (ROE)0.01
Return on Assets (ROA)0.01
Return on Invested Capital (ROIC)-61.17%
Return on Capital Employed (ROCE)-0.91
Revenue Per Employee1.82K
Profits Per Employee-63.31M
Employee Count39
Asset Turnover<0.01
Inventory Turnover1.35
Valuation Ratios
The current PE Ratio of PAVmed is ―. PAVmed’s PEG ratio is -0.10.
PE Ratio―
PS Ratio62.51
PB Ratio0.13
Price to Fair Value0.13
Price to FCF>-0.01
Price to Operating Cash Flow>-0.01
PEG Ratio-0.10
Income Statement
In the last 12 months, PAVmed had revenue of 71.00K and earned 401.00K in profits. Earnings per share was -5.63.
Revenue71.00K
Gross Profit-252.00K
Operating Income-21.81M
Pretax Income-2.47M
Net Income401.00K
EBITDA-21.70M
Earnings Per Share (EPS)-5.63
Cash Flow
In the last 12 months, operating cash flow was -2.62B and capital expenditures -47.00K, giving a free cash flow of -2.62B billion.
Operating Cash Flow-2.62B
Free Cash Flow-2.62B
Free Cash Flow per Share-366.48
Dividends & Yields
PAVmed pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.15
52-Week Price Change-67.56%
50-Day Moving Average8.63
200-Day Moving Average10.58
Relative Strength Index (RSI)33.72
Average Volume (3m)377.79K
Important Dates
PAVmed upcoming earnings date is Aug 18, 2026, Before Open (Confirmed).
Last Earnings DateMay 15, 2026
Next Earnings DateAug 18, 2026
Ex-Dividend Date―
Financial Position
PAVmed as a current ratio of 0.17, with Debt / Equity ratio of 43.04%
Current Ratio0.17
Quick Ratio0.16
Debt to Market Cap2.50
Net Debt to EBITDA-0.54
Interest Coverage Ratio-1.04K
Taxes
In the past 12 months, PAVmed has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
PAVmed EV to EBITDA ratio is -0.75, with an EV/FCF ratio of >-0.01.
EV to Sales228.85
EV to EBITDA-0.75
EV to Free Cash Flow>-0.01
EV to Operating Cash Flow>-0.01
Balance Sheet
PAVmed has $6.46M in cash and marketable securities with $17.01M in debt, giving a net cash position of -$10.55M billion.
Cash & Marketable Securities$6.46M
Total Debt$17.01M
Net Cash-$10.55M
Net Cash Per Share-$1.47
Tangible Book Value Per Share$33.26
Margins
Gross margin is -340.55%, with operating margin of -30712.68%, and net profit margin of 564.79%.
Gross Margin-340.55%
Operating Margin-30712.68%
Pretax Margin-3477.46%
Net Profit Margin564.79%
EBITDA Margin-30564.79%
EBIT Margin-30712.68%
Analyst Forecast
The average price target for PAVmed is $40.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$40.50
Price Target Upside422.58% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast-95.74%
EPS Growth Forecast-118.94%